Urgent.News

What's breaking now, across thousands of outlets.

Continued

Health & Medicine

Celltrion, Samsung Bioepis Battle Over Keytruda Biosimilar

As the patent expiration of the global top-selling mega blockbuster drug ‘Keytruda (ingredient name pembrolizumab)’ approaches, South Korea’s two biotechnology giants, Celltrion and Samsung Bioepis…

  • Celltrion leads biosimilar race with CT-P51, approved via fast-track
  • Samsung Bioepis counters with SB27, backed by phase 3 data from 600+ patients
  • Patent expiry in September creates crucial market battleground

World

KFS Highlightes 20 Years of Korea-Mongolia Green Belt Project at UNCCD

The Korea Forest Service (KFS), led by Minister Park Eun-sik, announced that Director General Lee Kwang Ho of the Forest Protection Bureau attended the 17th session of the Conference of the Parties…

  • Korea Forest Service marks 20 years of Korea-Mongolia Green Belt Project
  • Director General Lee Kwang Ho attended UNCCD conference in Mongolia
  • KFS discussed future strategies for public-private tree-planting initiatives

Business

SK Innovation Absorbs Separator Unit SKIET

SK Innovation and its separator business subsidiary SK IE Technology Co., Ltd. (SKIET) will merge. SK Innovation and SKIET said they each held board meetings on Aug.

  • SK Innovation merges with SKIET to enhance financial stability and efficiency.
  • New merger shares issued at 1:0.1174540 ratio for SKIET shareholders.
  • Merged company to list shares on January 18, 2024.
Continue reading →